glp 1 pre op A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia GLP-1 Medications Show Promise as
Description
GLP-1 receptor agonists (GLP-1RAs), initially approved for diabetes and obesity, are now under investigation for neuroprotective effects in a range of neurological disorders

11% clinical fatigue rate peaks week 4 titration

Retatrutide emerges as a promising multi-pathway therapeutic, attracting significant clinical interest for its potent effects on weight loss and metabolic control
Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, including with its GLP-1 medications.

Learn how different GLP-1 medications work, how they differ for weight loss vs diabetes and why dual agonists like tirzepatide stand out.
Not sure what GLP-1 is? Learn more here